# History and Physical

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Voltaire (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EN002-SYN-TD
- Date: 1778-04-06
- Fictional facility: St. Posthumous Health Center
- Fictional author: Honorine Delacroix-Mensah, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## Reason for visit

Primary care visit for three weeks of visible blood in the urine and difficult urination at 83. **S**

## Historical basis

- Voltaire, the pen name of François-Marie Arouet, was born in Paris; his birth certificate gives 21 November 1694, although he stated on several occasions that he was in fact born on 20 February. He was born into a wealthy bourgeois family; his putative father, François Arouet, became a receiver in the Cour des Comptes (the audit office), and he lost his mother when he was seven. He adopted the name Voltaire in 1718. **D**
- He was imprisoned in the Bastille for nearly a year in 1717 after mocking the regent, and in May 1726, after a quarrel with the chevalier de Rohan, was beaten, taken to the Bastille, and conducted to Calais, whence he left for London. **D**
- In a letter to the baron de Breteuil dated December 1723, he gave an account of the smallpox from which he was recovering: he fell ill on 4 November at Maisons; the disease declared itself after two days of fever with a slight eruption; the physician Gervasi had him take an emetic eight times and drink two hundred pints of lemonade, he had himself bled a second time on his own authority, and by the 15th he was out of danger. **D**
- His biographer Jean Orieux, as summarized in a 1970 review in the Revue d'histoire de la pharmacie, describes a lifelong preoccupation with illness and remedies: he suffered from colic, took as many as eight purges and twelve enemas in a month, was persuaded he would die before forty, and really did suffer from his kidneys and bladder. In a letter of 1769 he wrote that being very ill was the common lot of old age, especially for one who had always had a feeble constitution. **D**
- He returned to Paris on 10 February 1778, for the first time in 28 years, to direct rehearsals of his tragedy Irène; more than 300 people called on him the day after his arrival. On 30 March he went to the Académie amid acclamations and was crowned in his box at a performance of Irène. His deteriorating health did not permit his return to Ferney. **D**
- His secretary Jean-Louis Wagnière recorded that on 25 February 1778, at a quarter past noon, while dictating from his bed, he coughed three times and said that he was spitting blood, and that blood then spurted from his mouth and nose. A declaration in his hand of 2 March 1778 states that he had been attacked for four days by a vomiting of blood, and the blood loss continued for several days. **D**

6 later historical claims are omitted because they describe events after the index age. See the teaching note.

These claims are historical evidence, not findings from a real modern examination.

## History of present illness

This fictional modern episode addresses the presenting concerns below. **S**

- Blood in the urine and difficulty passing water for three weeks; afraid it is something serious. **S**
- Wants to finish the play he is staging and to keep writing, and does not want long stays in hospital. **S**
- Has always taken many remedies of his own choosing and asks for something strong to make him sleep. **S**

## Strengths and supports

- Engagement in care and meaningful activity **S**

## Medications and allergies

- Diphenhydramine 25 mg oral capsule, one capsule at night for sleep (over the counter) **S**
- Tamsulosin 0.4 mg oral capsule, one capsule at bedtime **S**
- Polyethylene glycol 3350, 17 g in a glass of water once daily **S**
- No known allergy **S**

## Past medical history

True biography with historical dates; these events are not part of the synthetic care timeline.

- 4 November 1723: Smallpox at 28, with two days of fever and then an eruption, treated with bleeding, emetics, and large amounts of lemonade; out of danger in eleven days **D** (CLM-0003)
- 1769 and throughout his life: Lifelong digestive complaints, colic, and frequent self-treatment with purges and enemas; complaints of the kidneys and bladder; a feeble constitution by his own account **D** (CLM-0004)
- 25 February 1778: Sudden bleeding from the mouth and nose after a fit of coughing, continuing for several days, six weeks before the index visit; source not established **D** (CLM-0006)

## Procedures and immunizations

- 1778-04-06 to 1778-04-06: Insertion of a 16 Fr two-way indwelling urethral catheter in the clinic: 520 mL of pink urine drained without clots **S**
- 1777-10-07: Influenza vaccine, high dose, 1777-1778 season **S**
- 1776-11-12: Pneumococcal conjugate vaccine PCV20 **S**
- 1773-06-03: Recombinant zoster vaccine, two-dose series completed **S**
- 1771-02-18: Tdap vaccine **S**
- 1776-10-01: Respiratory syncytial virus vaccine, single dose **S**

## Family history

- mother: Died when he was seven; cause not recorded in the cited source **D** (CLM-0001)
- father: A receiver in the audit office; his health and cause of death are not recorded in the cited sources **D** (CLM-0001)

## Measurements

Urine red cells: 75 /[HPF] (high); Urine white cells: 8 /[HPF] (high); IPSS: 22; Post-void residual (bladder scan): 460 mL (high); Hemoglobin: 11.6 g/dL (low); White blood cells: 7.8 10*3/uL; Platelets: 268 10*3/uL; Sodium: 138 mmol/L; Potassium: 5 mmol/L; Bicarbonate: 21 mmol/L (low); BUN: 34 mg/dL (high); Creatinine: 1.68 mg/dL (high); eGFR: 40 mL/min/1.73 m² (low); Glucose: 96 mg/dL; PSA: 6.4 ng/mL (high). All results are synthetic.

BP 138/72 mmHg; pulse 84 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 96% on room air; weight 54.2 kg; BMI 18.8 kg/m². All vital signs are synthetic.

## Examination

Mental status: Thin, quick, witty, and impatient; fully oriented; asks for the facts and wants to keep working. Functional status: Independent in activities of daily living; walks indoors and short distances outside with a stick; tires easily; needs help with shopping and travel. Physical examination is intentionally limited. **S**

## Assessment

1. Visible blood in the urine for three weeks with clots, and a weak stream, straining, and frequent small voids, in a man of 83; under evaluation; status draft. **S**
2. Chronic urinary retention with overflow (post-void residual 460 mL at intake), worsened by a nightly anticholinergic sleep aid; drained by an indwelling catheter; status draft. **S**
3. Acute kidney injury from bladder outlet obstruction (creatinine 1.68 mg/dL, from 1.1 mg/dL a year earlier); status draft. **S**
4. Chronic constipation, lifelong by his account, with long use of laxatives and self-given enemas; status draft. **S**

## Plan

- Hematuria evaluation: urinalysis with microscopy, urine culture, urine cytology, blood count, kidney function, multiphasic CT urography with CT of the chest, and cystoscopy. Guideline: Microhematuria: AUA/SUFU Guideline (2020; amended 2025) (2025); CMID: Clinical Monitoring Intelligence Database, urologic cancer and benign prostatic hyperplasia monographs (2026) **S**
- Urology consultation for gross hematuria with chronic retention: cystoscopy, resection if a tumor is found, the voiding trial, and the meaning of the PSA. Guideline: Microhematuria: AUA/SUFU Guideline (2020; amended 2025) (2025); Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia (BPH): AUA Guideline Amendment 2023 (2023); CMID: Clinical Monitoring Intelligence Database, urologic cancer and benign prostatic hyperplasia monographs (2026) **S**
- Retention: indwelling catheter now, tamsulosin at bedtime, catheter care teaching, then a trial without catheter with a bladder scan; IPSS and post-void residual at each visit. Guideline: Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia (BPH): AUA Guideline Amendment 2023 (2023); Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America (2009); CMID: Clinical Monitoring Intelligence Database, urologic cancer and benign prostatic hyperplasia monographs (2026) **S**
- Medication review: stop the diphenhydramine sleep aid and the over-the-counter sodium phosphate enemas; keep polyethylene glycol; cut coffee to two cups a day, none after noon; sleep advice without sedatives. Guideline: American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (2023); Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology (2018) **S**
- Shared decision on PSA testing: drawn before the catheter to interpret an enlarged, firm prostate, with the understanding that a raised value at 83 would lead to biopsy only if it would change treatment. Guideline: Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia (BPH): AUA Guideline Amendment 2023 (2023); Prostate Cancer: Screening (2018) **S**

## Guideline basis

- Microhematuria: AUA/SUFU Guideline (2020; amended 2025) (2025), American Urological Association and Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction
- Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia (BPH): AUA Guideline Amendment 2023 (2023), American Urological Association
- Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America (2009), Infectious Diseases Society of America
- American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (2023), American Geriatrics Society
- Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology (2018), American Society of Clinical Oncology
- Prostate Cancer: Screening (2018), U.S. Preventive Services Task Force
- CMID: Clinical Monitoring Intelligence Database, urologic cancer and benign prostatic hyperplasia monographs (2026), Aether Forge
